Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 1-year Randomised, Double-blind Placebo-controlled Study to Evaluate the Effects of Memantine on Rate of Brain Atrophy in Patients With Alzheimer's Disease

NCT00862940 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT00862940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00862940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 1-year Randomised, Double-blind Placebo-controlled Study to Evaluate the Effects of Memantine on Rate of Brain Atrophy in Patients With Alzheimer's Disease
Lead sponsor
H. Lundbeck A/S
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
April 30, 2009
Enrollment
277 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease